BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liang J, Tian XF, Yang W. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. World J Gastroenterol 2020; 26(13): 1474-1489 [PMID: 32308348 DOI: 10.3748/wjg.v26.i13.1474]
URL: https://www.wjgnet.com/1007-9327/full/v26/i13/1474.htm
Number Citing Articles
1
Taohua Yue, Xiangzheng Liu, Shuai Zuo, Jing Zhu, Jichang Li, Yucun Liu, Shanwen Chen, Pengyuan Wang. BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer PatientsFrontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.799278
2
Shuo Li, Mingxing Tang, Nan Zen, Junyi Liang, Xiao Xing, Danglin Huang, Fei Liu, Xiaomeng Zhang. LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.921929
3
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, Yousif Mohammed Younis, Hazha Jamal Hidayat, Mohammed Fatih Rasul, Sayran Mohamadtahr. Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targetsNon-coding RNA Research 2023; 8(4): 615 doi: 10.1016/j.ncrna.2023.09.001
4
Serena Wooten, Keriayn N. Smith. Long non‐coding RNA OIP5‐AS1 (Cyrano): A context‐specific regulator of normal and disease processesClinical and Translational Medicine 2022; 12(1) doi: 10.1002/ctm2.706
5
Amar Balihodzic, Felix Prinz, Michael A. Dengler, George A. Calin, Philipp J. Jost, Martin Pichler. Non-coding RNAs and ferroptosis: potential implications for cancer therapyCell Death & Differentiation 2022; 29(6): 1094 doi: 10.1038/s41418-022-00998-x
6
远哲 荣. Research Progress on Reversing Oxaliplatin Resistance in Colon CancerAdvances in Clinical Medicine 2023; 13(08): 12687 doi: 10.12677/ACM.2023.1381779
7
Yifan Shao, Yuwei Dong, Jing Zhou, Zhihua Lu, Chen Chen, Xiaomin Yuan, Linhai He, Wenwen Tang, Zepeng Chen, Yuji Wang, Qiurong Li, Shuhui Zhan, Zhengxi Qiu, Kuiling Wang, Jiaze Ma, Yugen Chen, Yang Li. Advances in the study of antisense long‑stranded non‑coding RNAs in tumors (Review)International Journal of Oncology 2024; 64(3) doi: 10.3892/ijo.2024.5610
8
Cheng Zheng, Man Chu, Qiuli Chen, Cheng Chen, Zhi-Wei Wang, Xiao Chen. The role of lncRNA OIP5-AS1 in cancer development and progressionApoptosis 2022; 27(5-6): 311 doi: 10.1007/s10495-022-01722-3
9
Zheng-Dong Luo, Yi-Feng Wang, Yu-Xiao Zhao, Long-Chen Yu, Tian Li, Ying-Jing Fan, Shun-Jie Zeng, Yan-Li Zhang, Yi Zhang, Xin Zhang. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potentialWorld Journal of Gastroenterology 2023; 29(1): 1-18 doi: 10.3748/wjg.v29.i1.1
10
Soudeh Ghafouri-Fard, Sepideh Dashti, Molood Farsi, Bashdar Mahmud Hussen, Mohammad Taheri. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignanciesBiomedicine & Pharmacotherapy 2021; 137: 111366 doi: 10.1016/j.biopha.2021.111366
11
Yan Wang, Changkun Lin, Yang Liu. Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cellsCancer Gene Therapy 2022; 29(5): 612 doi: 10.1038/s41417-021-00342-4
12
Tae Won Kim, Haein Ji, Nak Hyeon Yun, Chang Hoon Shin, Hyeon Ho Kim, Yong Beom Cho. Two antisense RNAs—AFAP1-AS1 and MLK7-AS1—promote colorectal cancer progression by sponging miR-149-5p and miR-485-5pMolecular Therapy - Nucleic Acids 2023; 33: 305 doi: 10.1016/j.omtn.2023.07.004
13
Biao Liu, Wei Xiang, Jiahao Liu, Jin Tang, Jinrong Wang, Bin Liu, Zhi Long, Long Wang, Guangming Yin, Jianye Liu. The regulatory role of antisense lncRNAs in cancerCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02168-4